eniwru

Notice: Google Translator translates the texts only for guidance.

CBD applications

CBD applications

Medical research and information

Journal “Frontiers in Pharmacology”, January 2021 Department of Psychiatry, UMC Utrecht Brain Center, Netherlands.

Accumulating evidence suggests that cannabidiol (CBD) may have antipsychotic and anxiolytic properties and thus may be a promising new treatment for psychotic and anxiety disorders. To date, ninety-four studies have been published. All studies examined the effect of isolated CBD on brain function in healthy volunteers and people diagnosed with a mental disorder at rest or in the context of cognitive tasks. In healthy volunteers, CBD enhanced resting fronto-striatum connectivity both compared to placebo and THC.

In addition, CBD modulated brain activity and had opposite effects compared to THC, in various cognitive paradigms, such as emotional processing (frontotemporal), verbal memory (fronto-striatum), inhibition of reaction (fronto-limbic-striatum). ) and auditory / visual processing (temporo-occipital). In people with clinically high risk of psychosis and patients with established psychosis, CBD showed intermediate brain activity compared to placebo and healthy controls during cognitive tasks. CBD modulated resting limbic activity in subjects with anxiety and in patients with autism spectrum disorders.

Neuroimaging studies have shown that isolated CBD induces significant changes in brain activity and communication patterns at rest and cognitive task performance in both healthy volunteers and patients with mental illness. This included modulation of functional networks related to mental disorders, possibly reflecting the therapeutic effects of CBD.

Our services

Our company UNIMED SGS Ltd is the distributor for Dragonfly Biosciences Limited, United Kingdom. We offer high-quality CBD bulk, white label and wholesale solutions.

Wholesale options

  • White labelling
  • Bulk Extract/Formulation on request
  • Bespoke formulation requests also available
  • Flavours & additional ingredients available on request
  • R&D Fee for unique formulation, three amendments with samples

Contact us

Disclaimer

©2021 UNIMED SGS Ltd. All rights reserved. All trade marks on this website are the property of their respective owners.

Sorry, this website uses features that your browser doesn’t support. Upgrade to a newer version of Firefox, Chrome, Safari, or Edge and you’ll be all set.